Opportunities and challenges to engineer 3D models of tumor-adaptive immune interactions
Augmenting adaptive immunity is a critical goal for developing next-generation cancer therapies.T and B cells infiltrating the tumor dramatically influence cancer progression through complex interactions with the local microenvironment.Cancer cells evade and limit these immune responses by hijacking normal immunologic pathways.Current experimental